Searchable abstracts of presentations at key conferences in endocrinology

ea0065p9 | Adrenal and Cardiovascular | SFEBES2019

Exploring diagnostic thresholds for adrenal insufficiency with the new generation Roche cortisol assay

Daultrey Harriet , Chakera Ali , Crown Anna

Introduction: In 2017 the Roche cortisol assay underwent a generation update. The increased specificity of this assay was expected to lower cortisol results by approximately 30%. Based on a local consensus, the 30 min short Synacthen Test (SST) cortisol was lowered from 550 to 420 nmol/l. With the previous assay, a morning cortisol of ≥375 nmol/L gave a 99% PPV of an SST ‘pass’.Aims: • To compare the numbers of SSTs and the SST pass ...

ea0065p339 | Nursing practice | SFEBES2019

Use of a holistic needs assessment questionnaire to inform ‘late effects’ clinic appointments for childhood cancer survivors

McGoldrick Sophie , Crown Anna , Davidson Anne

The number of childhood cancer survivors is ever increasing and as this population continues to grow, the long term physical and psychological impact of having cancer treatment in childhood becomes ever more apparent. Childhood cancer survivors are moving into adulthood with significant health needs secondary to their cancer treatment. Acknowledging and addressing these needs is crucial in supporting them on their continued health journey. Patients attending the ‘late eff...

ea0063gp21 | Calcium and Bone 1 | ECE2019

The long-term outcomes of chronic post-surgical hypoparathyroidism

Mokrysheva Natalia , Eremkina Anna , Kovaleva Elena

Hypoparathyroidism (HP) is a rare disease characterized by an absence or inappropriately low concentrations of circulating parathyroid hormone, leading to hypocalcaemia, hypophosphatemia and elevated urinary calcium excretion.Aim: To determine complications in chronic post-surgical HP patients.Material and methods: We have analyzed the data from 76 patients (71 women and 5 men; median age 51.8 years (range 18–77)) with chronic...

ea0063p94 | Calcium and Bone 1 | ECE2019

Osteitis Fibrosa Cystica – A Forgotten Clinical And Radiological Feature Of Primary Hyperparathyroidism

Katharina Flugel Anna , Mondorf Antonia , Bojunga Jorg

Introduction: Manifestations of primary hyperparathyroidism (PHPT) such as osteoporosis and stone diseases are common primary diagnostic findings beyond a hypercalcemia. Classical skeletal involvement can be the first sign of PHPT, but not recognized because osteitis fibrosa cystica (bone cysts, brown tumors of the long bones) is rarely seen today in Western Europe.Case report: A 34-year old women from Afghanistan was presented to our out-patient-clinic ...

ea0063p133 | Diabetes, Obesity and Metabolism 1 | ECE2019

A1c level in people with newly diagnosed type 2 diabetes during screening

Alieva Anna , Ismailov Saydiganikhodja , Rakhimova Gulnara

Background: There are about 50% of people living with undiagnosed diabetes worldwide. Moreover, by the time of diabetes diagnosis, chronic disabling complications are already present.Aim: To assess level of A1c by the time of type 2 diabetes diagnosis.Material and methods: We analyzed results of type 2 diabetes screening in three regions of the Republic of Uzbekistan among 2521 people aged 35 or older without known carbohydrates me...

ea0063p295 | Pituitary and Neuroendocrinology 1 | ECE2019

Silent, isolated ACTH-deficiency in melanoma patients treated with immune checkpoint inhibitors

Heck Ansgar , Winge-Main Anna K.

Background: The incidence of hypophysitis has increased since the introduction of Immuno-oncologic treatment. Treatment with anti-CTLA-4 (Ipilimumab) and anti-PD-1 has improved the prognosis for patients with malign melanoma drastically, but immune-mediated side effects can occur in any organ, including the thyroid and the pituitary. Headache is considered a key symptom of hypophysitis. Here, we report three cases with silent, isolated ACTH-insufficiency following immunotherap...

ea0049oc2.2 | Diabetes Prediction and Complications | ECE2017

Effectiveness of complex therapy in patients with comorbidity of type 2 diabetes and essential hypertension depending on genetic polymorphism PPARγ2

Shalimova Anna , Bilovol Oleksandr , Bobronnikova Lesya

The aim: To evaluate effectiveness of complex therapy in patients with comorbidity of type 2 diabetes (DM2) and essential hypertension (EH) depending on genetic polymorphism peroxisome proliferator-activating receptor-γ2 (PPARγ2). Before and after 3 months of treatment we examined 145 patients with EH stage II, grade and DM2 moderate, subcompensated aged 45–60 years: group 1 (71 patients) received standart therapy (telmisartan, indapamide, metformin, gliclazide,...

ea0049gp115 | Endocrine Nursing | ECE2017

Education, patient empowerment and admission avoidance

Hawkins Anna , Casey Edel , Nikookam Khash

It is paramount to educate our patients, thereby empowering them to manage their chronic conditions. This is an evidence based fact. As healthcare professionals our challenge is to provide and ensure patients have been well informed in order to understand and manage their condition successfully on a daily basis.In today’s healthcare service patient education has become a casualty of the reduced resources; there are ever increasing restrictions on bo...

ea0049ep78 | Adrenal cortex (to include Cushing's) | ECE2017

Hyperaldosteronism screening in Hypertensiologists experience - epidemiological review of over 800 cases

Korzynska Weronika , Jodkowska Anna , Mazur Grzegorz

Primary aldosteronism (PHA) is one of the most common cause of secondary hypertension. It can possibly concern over 10% of hypertensive patients, but often is being under-recognised. The basic tool of case PHA detection is aldosterone to renin ratio (ARR). Appropriate cutoff value of ARR is still under discussion.We review occurrence of CT/MRI detectable adrenal gland laesions according to assigned ARR cutoff value. Retrospective data from 833 consecutiv...

ea0049ep650 | Obesity | ECE2017

The case of 36 years old obese male patient with high degree of proteinuria and a loosing weight as the major strategy of treatment

Katamadze Natia , Chochishvili Natalia , Shamanadze Anna

Introduction: Obesity-related glomerulopathy(ORG) is a secondary form of focal segmental glomerulosclerosis (FSGS) occurring in obese patients with a body mass index(BMI) higher than 30 kg/m2.ORG is typically manifested by nephrotic-range proteinuria without full nephrotic syndrome, and progressive renal insufficiency.Case presentation: Thirty-six years old male patient (BMI 59.2 kg/m2) visited endocrinologist with complains of weig...